Analyst Price Target is $1.25
This price target is based on 0 analysts offering 12 month price targets for Invesque in the last 3 months. The average price target is $1.25, with a high forecast of $1.25 and a low forecast of $1.25. The average price target represents a 0.00% upside from the last price of $1.25.
Current Consensus is
The current consensus among 0 contributing investment analysts is to n/a stock in Invesque. This rating changed within the last month from a Hold consensus rating.
Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.